Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 925

1.

Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats.

Munzar P, Laufert MD, Kutkat SW, Nováková J, Goldberg SR.

J Pharmacol Exp Ther. 1999 Oct;291(1):239-50.

PMID:
10490910
[PubMed - indexed for MEDLINE]
Free Article
2.

Differential involvement of 5-HT(2A) receptors in the discriminative-stimulus effects of cocaine and methamphetamine.

Munzar P, Justinova Z, Kutkat SW, Goldberg SR.

Eur J Pharmacol. 2002 Feb 1;436(1-2):75-82.

PMID:
11834249
[PubMed - indexed for MEDLINE]
4.

Role of 5-hydroxytryptamine1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats.

Filip M, Nowak E, Papla I, Przegaliński E.

J Physiol Pharmacol. 2001 Jun;52(2):249-63.

PMID:
11453104
[PubMed - indexed for MEDLINE]
Free Article
5.

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.

Rasmussen K, Calligaro DO, Czachura JF, Dreshfield-Ahmad LJ, Evans DC, Hemrick-Luecke SK, Kallman MJ, Kendrick WT, Leander JD, Nelson DL, Overshiner CD, Wainscott DB, Wolff MC, Wong DT, Branchek TA, Zgombick JM, Xu YC.

J Pharmacol Exp Ther. 2000 Aug;294(2):688-700.

PMID:
10900249
[PubMed - indexed for MEDLINE]
Free Article
6.

Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats.

Munzar P, Goldberg SR.

Psychopharmacology (Berl). 1999 Apr;143(3):293-301.

PMID:
10353433
[PubMed - indexed for MEDLINE]
7.

Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.

Callahan PM, Cunningham KA.

J Pharmacol Exp Ther. 1995 Sep;274(3):1414-24.

PMID:
7562516
[PubMed - indexed for MEDLINE]
8.

Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.

Justinova Z, Ferre S, Segal PN, Antoniou K, Solinas M, Pappas LA, Highkin JL, Hockemeyer J, Munzar P, Goldberg SR.

J Pharmacol Exp Ther. 2003 Dec;307(3):977-86. Epub 2003 Oct 13.

PMID:
14557381
[PubMed - indexed for MEDLINE]
Free Article
9.

Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test.

Dias Elpo Zomkowski A, Oscar Rosa A, Lin J, Santos AR, Calixto JB, Lúcia Severo Rodrigues A.

Brain Res. 2004 Oct 15;1023(2):253-63.

PMID:
15374751
[PubMed - indexed for MEDLINE]
10.

Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT 1A/1B/2C receptors.

Miranda F, Hong E, Sánchez H, Velázquez-Martínez DN.

Pharmacol Biochem Behav. 2003 Jan;74(2):371-80.

PMID:
12479957
[PubMed - indexed for MEDLINE]
11.

Involvement of spinal serotonin receptors in the regulation of intraspinal acetylcholine release.

Kommalage M, Höglund AU.

Eur J Pharmacol. 2005 Feb 21;509(2-3):127-34.

PMID:
15733547
[PubMed - indexed for MEDLINE]
13.

Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.

Sánchez H, Velázquez-Martínez DN.

J Psychopharmacol. 2001 Mar;15(1):29-36.

PMID:
11277605
[PubMed - indexed for MEDLINE]
14.

Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.

Batman AM, Munzar P, Beardsley PM.

Psychopharmacology (Berl). 2005 May;179(2):393-401. Epub 2004 Nov 25.

PMID:
15565434
[PubMed - indexed for MEDLINE]
15.

The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.

Lucas G, De Deurwaerdère P, Caccia S, Umberto Spampinato.

Neuropharmacology. 2000 Apr 3;39(6):1053-63.

PMID:
10727716
[PubMed - indexed for MEDLINE]
16.

Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.

Bristow LJ, O'Connor D, Watts R, Duxon MS, Hutson PH.

Neuropharmacology. 2000 Apr 27;39(7):1222-36.

PMID:
10760364
[PubMed - indexed for MEDLINE]
17.

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.

Eur J Pharmacol. 2005 Mar 7;510(1-2):49-57.

PMID:
15740724
[PubMed - indexed for MEDLINE]
18.

5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.

Moser PC, Sanger DJ.

Eur J Pharmacol. 1999 May 14;372(2):127-34.

PMID:
10395092
[PubMed - indexed for MEDLINE]
19.

Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.

Van de Kar LD, Raap DK, Battaglia G, Muma NA, Garcia F, DonCarlos LL.

Neuropharmacology. 2002 Jul;43(1):45-54.

PMID:
12213258
[PubMed - indexed for MEDLINE]
20.

The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.

Mos J, Van Hest A, Van Drimmelen M, Herremans AH, Olivier B.

Eur J Pharmacol. 1997 May 1;325(2-3):145-53.

PMID:
9163561
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk